Zhong Jin Zai Xian·2025-06-09 09:18Group 1 - The core viewpoint of the articles highlights the launch of Santen's flagship product, Vitamin B12 Eye Drops (Santen Rose®), on JD Health, emphasizing its upgraded design and effectiveness in alleviating visual fatigue [1][2] - The product is backed by clinical research showing a 66.1% efficacy rate in patients using the eye drops alone, compared to 62.5% in those using a combination treatment [2] - JD Health aims to leverage its extensive user base and comprehensive healthcare service system to enhance the market reach and accessibility of Santen Rose® [2] Group 2 - The launch coincides with the increasing prevalence of visual fatigue due to the "screen reading era," creating significant demand for eye drops among younger consumers [1] - Santen Rose® is imported from Japan and packaged in a GMP-certified facility, ensuring high quality and user-friendly design [1] - JD Health's commitment to user health needs and its strategic partnership with Santen will facilitate easier access to this professional eye care product for consumers [2]